A simple and valid tool distinguished efficacy from effectiveness studies

被引:164
作者
Gartlehner, Gerald
Hansen, Richard A.
Nissman, Daniel
Lohr, Kathleen N.
Carey, Timothy S.
机构
[1] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Pharm, Div Pharmaceut Policy & Evaluat Sci, Chapel Hill, NC 27599 USA
[3] Med Univ S Carolina, Dept Radiol, Charleston, SC 29425 USA
[4] RTI Int, Res Triangle Pk, NC USA
关键词
effectiveness; efficacy; pragmatic studies; explanatory studies; systematic reviews; methods study;
D O I
10.1016/j.jclinepi.2006.01.011
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To propose and test a simple instrument based on seven criteria of study design to distinguish effectiveness (pragmatic) from efficacy (explanatory) trials. Study Design: Currently no validated definition of effectiveness studies exists. We asked the directors of 12 Evidence-based Practice Centers to select six studies each: four that they considered to be examples of effectiveness trials and two considered efficacy studies. We then applied our proposed criteria to test the construct validity using the selected studies as if they had been identified by a gold standard. Results: Based on the rationale to identify effectiveness studies reliably with minimal false positives (i.e., a high specificity), a cutoff of six criteria produced the most desirable balance between sensitivity and specificity. This setting produced a specificity of 0.83 and a sensitivity of 0.72. Conclusion: When applied in a standardized manner, our proposed criteria can provide a valid and simple tool to distinguish effectiveness from efficacy studies. The applicability of systematic reviews can improve when analysts place more emphasis on the generalizability of included studies. In addition, clinicians can also use our criteria to determine the external validity of individual studies, given an appropriate population of interest. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1040 / 1048
页数:9
相关论文
共 57 条
[1]  
[Anonymous], 1986, Lancet, V1, P397
[2]  
[Anonymous], 2001, 4 CRD
[3]   Patients' decisions about whether or not to take antihypertensive drugs: qualitative study [J].
Benson, J ;
Britten, N .
BRITISH MEDICAL JOURNAL, 2002, 325 (7369) :873-876A
[4]   Effectiveness and cost-benefit of influenza vaccination of healthy working adults - A randomized controlled trial [J].
Bridges, CB ;
Thompson, WW ;
Meltzer, MI ;
Reeve, GR ;
Talamonti, WJ ;
Cox, NJ ;
Lilac, HA ;
Hall, H ;
Klimov, A ;
Fukuda, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (13) :1655-1663
[5]   EFFICACY, EFFECTIVENESS, VARIATIONS, AND QUALITY - BOUNDARY-CROSSING RESEARCH [J].
BROOK, RH ;
LOHR, KN .
MEDICAL CARE, 1985, 23 (05) :710-722
[6]   Principles from clinical trials relevant to clinical practice: Part I [J].
Califf, RM ;
DeMets, DL .
CIRCULATION, 2002, 106 (08) :1015-1021
[7]  
Clarke J, 2005, LANCET, V365, P764, DOI 10.1016/S0140-6736(05)17983-5
[8]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[9]   A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder [J].
Conley, RR ;
Mahmoud, R .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (05) :765-774
[10]   MEASURING COMPLIANCE WITH INHALED MEDICATION IN ASTHMA [J].
COUTTS, JAP ;
GIBSON, NA ;
PATON, JY .
ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (03) :332-333